Arbutus Biopharma Cash Flow Statement (2010-2025) | ABUS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-16.38M	-19.39M	-19.16M	-21.32M	-15.77M	-14.19M	-17.57M	-21.93M	-16.34M	-17.09M	-20.10M	-19.31M	-17.86M	-19.79M	-19.72M	-12.50M	-24.53M	2.50M	-7.73M	-4.43M
Depreciation and Depletion (Quarter)	0.44M	0.44M	0.45M	0.43M
Share-based Compensation (Quarter)	1.64M	1.74M	1.61M	1.43M	1.74M	2.06M	1.72M	1.67M	2.13M	2.96M	2.48M	1.72M	2.01M	3.18M	2.16M	1.63M	3.56M	0.86M	1.26M	1.26M
Deferred Taxes (Quarter)
Gains from Investment Securities (Quarter)	0.13M	-0.13M	1.68M	0.19M	0.20M	-0.18M	0.60M	-0.62M	0.27M	-0.64M	0.38M		0.18M	0.21M	0.34M	1.89M	0.30M	0.30M	0.23M	-0.15M
Asset Writedowns and Impairment (Quarter)
Cash from Restructuring (Quarter)
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-17.88M	-14.01M	-16.04M	-19.61M	20.62M	-20.29M	-18.69M	-16.99M	-27.30M	-19.56M	-21.78M	-17.29M	-19.30M	-14.50M	-20.74M	-10.31M	-13.39M	-15.75M	-5.82M	-4.68M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
Amortizatization of Intangibles (Quarter)	-0.16M	-0.29M	-0.30M	-0.25M	-0.17M	-0.08M	0.08M	0.22M	0.39M	0.53M	0.66M	0.62M	0.55M	0.68M	0.98M	0.92M	0.72M	0.67M	0.54M	0.42M
Depreciation & Amortization (CF) (Quarter)	0.44M	0.44M	0.45M	0.43M	0.39M	0.38M	0.34M		0.33M	0.34M	0.37M		0.35M	0.36M	0.34M		0.33M	0.01M	0.01M
Change in Working Capital
Change in Receivables (Quarter)	-0.05M	0.03M	0.37M	-0.77M	0.41M	0.66M	-0.14M	-0.48M	1.31M	-0.05M	-0.44M	-0.40M	0.36M	-0.37M	-0.16M	0.80M	-1.23M	-0.16M	-0.12M	0.13M
Change in Accured Expenses (Quarter)	-2.80M	2.68M	-0.12M	2.15M	-0.07M	-0.07M	-0.13M	5.50M	-6.38M	6.23M	-0.14M	-0.15M	-0.07M	-0.08M	-2.58M	0.02M	-0.10M	-0.12M	-2.69M	0.81M
Change in Taxes (Quarter)
Investing Activities
Capital Expenditures (Quarter)	0.10M	0.63M	0.02M	0.06M	0.07M	0.21M	0.09M	0.13M	0.12M	0.86M	0.03M		0.10M	0.00M		0.09M
Sales of Property, Plant and Equipment (Quarter)								-0.02M			0.02M									0.35M
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)	20.35M	14.00M	16.00M	20.00M	2.00M	9.00M	19.00M	26.00M	37.00M	31.50M	17.53M	46.24M	37.19M	42.41M	28.35M	56.69M	46.06M	44.10M	41.28M	23.83M
Cash from Investing Activities (Quarter)	18.22M	-38.75M	15.97M	-8.12M	-60.06M	-13.83M	-13.74M	12.68M	16.68M	1.44M	10.43M	22.23M	11.69M	9.83M	-11.99M	13.41M	11.35M	15.61M	-10.02M	-1.36M
Financing Activities
Other financing activities (Quarter)
Debt Issuance and Repayment
Long-Term Debt Repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	0.21M	26.40M	75.40M	-1.76M	0.01M	0.30M	9.00M	0.27M	0.30M	4.70M	1.40M	0.28M	0.21M	22.40M	0.18M		2.65M	0.45M	-2.92M	5.36M
Preferred Shares Issued (Quarter)
Dividend Payments
Dividends Paid - Preferred (Quarter)	3.21M	3.27M	5.09M	0.57M
Misc.
Cash from Financing Activities (Quarter)	26.87M	4.29M	46.95M	59.12M	11.48M	0.11M	9.13M	11.08M	20.42M	4.74M	1.68M	3.81M	24.43M	24.37M	1.77M	1.42M	2.78M	0.45M	0.84M	1.64M
Exchange Rate Effect (Quarter)	-0.04M		0.04M	0.01M			-0.02M	-0.00M	0.00M	-0.00M	0.01M	0.01M	-0.01M	-0.01M	0.01M	-0.03M	0.00M	0.02M	-0.01M	0.00M
Change in Cash (Quarter)	27.17M	-48.47M	46.93M	31.40M	-27.95M	-34.01M	-23.32M	6.77M	9.80M	-13.38M	-9.67M	8.75M	16.82M	19.69M	-30.94M	4.48M	0.75M	0.34M	-15.00M	-4.40M
Free Cash Flow (Quarter)	-17.98M	-14.64M	-16.06M	-19.66M	20.54M	-20.50M	-18.78M	-17.12M	-27.42M	-20.42M	-21.82M	-17.29M	-19.39M	-14.51M	-20.74M	-10.40M	-13.39M	-15.75M	-5.82M	-4.68M
Net Cash Flow (Quarter)	27.21M	-48.47M	46.88M	31.39M	-27.95M	-34.01M	-23.30M	6.78M	9.79M	-13.38M	-9.67M	8.74M	16.83M	19.70M	-30.95M	4.52M	0.74M	0.32M	-14.99M	-4.40M

Research Tools

Arbutus Biopharma Cash Flow Statement (2010-2025) | ABUS

Create an account

Sign In

Reset Password